Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Clinical Practice
Home
A peer-reviewed clinical neurology journal for the practicing neurologist
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Practice Current
  • Practice Buzz

Share

December 2013; 3 (6) Practice Across Borders

Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease

GraphicFRANCE

François Tison, Wassilios G. Meissner
First published December 9, 2013, DOI: https://doi.org/10.1212/01.CPJ.0000437017.29917.c9
François Tison
for the French Parkinson's Disease Expert Centers; Service de Neurologie, CHU de Bordeaux, Pessac, France; Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wassilios G. Meissner
for the French Parkinson's Disease Expert Centers; Service de Neurologie, CHU de Bordeaux, Pessac, France; Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease
GraphicFRANCE
François Tison, Wassilios G. Meissner
Neurol Clin Pract Dec 2013, 3 (6) 480-481; DOI: 10.1212/01.CPJ.0000437017.29917.c9

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
41

Share

  • Article
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

In France, newly diagnosed patients with Parkinson disease (PD) are mostly referred by a general practitioner (GP) to a public (hospital-based) or private practice neurologist for confirmation of the diagnosis and treatment initiation. Most neurologists rely on a clinical evaluation according to National Health Authority (HAS) recommendations and guidelines.1 MRI scans and dopamine transporter imaging are increasingly being performed for the differential diagnosis of atypical parkinsonism, for drug-induced parkinsonism and tremor, in early-onset patients, or to deal with the anxiety of patients and their families. Clinical scales such as the Unified Parkinson's Disease Rating Scale are scarcely used in routine practice. Therapeutic strategies are not or little affected by who is covering the cost of treatment or by how medical facilities and professionals are reimbursed, ensuring that health care guidelines are usually respected. Indeed, the expenses for drugs and other inpatient and ambulatory health care are almost fully covered by the health insurance within the frame of chronic diseases (“Affection de longue durée n°16”), providing that the parkinsonian syndrome is irreversible and requires the administration of antiparkinsonian drugs for at least 6 months. Some newly diagnosed patients, before being registered by the free care system for chronic diseases, may only have partial coverage of costs (65%). However, most of them have complementary private insurance allowing full reimbursement of their expenses.

Footnotes

  • Study funding: No targeted funding reported.

  • Disclosures: F. Tison has served on scientific advisory boards for Novartis, UCB, Boehringer-Ingelheim, GlaxoSmithKline, and ABBOTT; has received funding for travel from GlaxoSmithKline, Lundbeck, Novartis, TEVA, and UCB; serves as a consultant for ADDEX Pharma; and receives research support from Novartis, the French Ministry of Health, the University Hospital Bordeaux, and the Michael J. Fox Foundation. W. G. Meissner has served on scientific advisory boards for ANM GmbH and Novartis; has served on speakers bureaus for and received funding for travel and/or speaker honoraria from GSK, Expression Santé, Lundbeck, Novartis, TEVA, and UCB; serves on the editorial board of the Journal of Neural Transmission; and has received research funding from the Michael J. Fox Foundation, the University Hospital Bordeaux, the French Health Ministry, APTES (French patient association for essential tremor), and PSP-France, as well as unrestricted research grants from Novartis and TEVA/Lundbeck. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

  • © 2013 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Education
  • Models of care
  • Parkinson's disease/Parkinsonism

Alert Me

  • Alert me when eletters are published
Neurology: Clinical Practice: 12 (3)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Clinical Practice |  Print ISSN: 2163-0402
Online ISSN: 2163-0933

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise